Page last updated: 2024-10-26

diclofenac and Corneal Angiogenesis

diclofenac has been researched along with Corneal Angiogenesis in 2 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Shi, H1
Zhu, Y1
Xing, C1
Li, S1
Bao, Z1
Lei, L1
Lin, D1
Wang, Y1
Chen, H1
Xu, X1
Dana, MR1
Streilein, JW1

Other Studies

2 other studies available for diclofenac and Corneal Angiogenesis

ArticleYear
An injectable thermosensitive hydrogel for dual delivery of diclofenac and AvastinĀ® to effectively suppress inflammatory corneal neovascularization.
    International journal of pharmaceutics, 2022, Sep-25, Volume: 625

    Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Biocompatible Materials; Corneal Neovascularization;

2022
Loss and restoration of immune privilege in eyes with corneal neovascularization.
    Investigative ophthalmology & visual science, 1996, Volume: 37, Issue:12

    Topics: Animals; Anterior Chamber; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cornea

1996